Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.

Susumu SakamotoKensuke KataokaYasuhiro KondohMotoyasu KatoMasaki OkamotoHiroshi MukaeMasashi BandoTakafumi SudaKazuhiro YateraYoshinori TaninoTomoo KishabaNoboru HattoriYoshio TaguchiTakefumi SaitoYasuhiko NishiokaKazuyoshi KuwanoKazuma KishiNaohiko InaseShinichi SasakiHajime TakizawaTakeshi JohkohFumikazu SakaiSakae Hommanull null

Published in: The European respiratory journal (2021)

Combination treatment with inhaled N-acetylcysteine and pirfenidone is likely to result in worse outcomes for IPF.

Keyphrases

idiopathic pulmonary fibrosis
interstitial lung disease
cystic fibrosis
study protocol
open label
randomized controlled trial
type diabetes
clinical trial
metabolic syndrome
adipose tissue
skeletal muscle